Medlar bodies; muriform bodies; copper pennies.
Affecting mostly adult male agricultural workers in the rural tropical and subtropical areas of the world.
Chronic granulomatous infection of the skin and subcutaneous tissue caused by several different brown pigment-producing (dematiaceous) fungi.
Aetiology & Pathogenesis
A large number of dematiaceous, i.e.brown pigment producing, fungi can cause the disease, the most common of which are Cladosporium carrionii, Phialophora verrucosa, and Fonsecaea pedrosoi, present in wood an soil.
Signs & Symptoms
Localized, slowly growing and peripherally extending, warty cauliflower-like plaques, which may ulcerate. Sclerotic bodies are extruded tranaepidermally, appearing as black dots. Large hyperkeratotic and ulcerating masses may form. The lesion is usually painless. Sometimes lymphatic spread due to scratching result in the sporotrichoid pattern. Hematogenous dissemination with brain abscesses is very rare.
Areas exposed to trauma.
Laboratory & other workups
Microbiology; 10% KOH.
Marked pseudoepitheliomatous hyperplasia of the epidermis. Transepidermal elimination of fungal cells, which are in the stratum corneum. Foreign-body granuloma with isolated microabscesses. In the dermis, a granuloma composed of epithelioid cells and Langhans giant cells is visible. The golden-brown fungal elements are visible as thick-walled, single, or multicelled clusters, forming sclerotic or muriform bodies.
Chronic, but curable. The prognosis depends on the size of the lesions and the immune status of the patient. Long-standing cases can spread over joints and lead to lymphatic involvement and elephantiasis. Disseminated disease, with the involvement of the central nervous system, has the worst prognosis.
Ulceration, secondary bacterial infection, lymphedema resulting in elephantiasis. Malignant transformation to squamous cell carcinoma is rare.
Clinical feature, histologic and microbial findings.
Prevention & Therapy
Prevention of trauma.
Best results are achievable in small lesions with surgery, cryotherapy or electrodessiccation in combination with antifungal therapy: itraconazole 200 to 400 mg/day or terbinafine, 250 to 500 mg/day given for a period varying from 6 months to a year or more. Flucytosine alone or combined with amphotericin and oral supersaturated potassium iodide solution are additional options.
Best management is by an interprofessional team, including an infectious disease consultant, surgeon, emergency department physician, wound care nurse, and an internist.
- G. Kurien, K. Sugumar, V. Chandran: Chromoblastomycosis
- A.C. de Brito, M. de Jesus Semblano Bittencourt: Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update*
- O. Lupi, S.K. Tyring, M.R. McGinnis: Tropical dermatology: Fungal tropical diseases
- F. Queiroz-Telles, S. de Hoog, D.W. C. L. Santos, et al.: Chromoblastomycosis
Be the first one to leave a comment!